Australia markets close in 22 minutes

iTeos Therapeutics, Inc. (ITOS)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
14.89+0.09 (+0.61%)
At close: 04:00PM EDT
14.89 0.00 (0.00%)
After hours: 04:56PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
261,071
-112,642
96,652
214,521
-38,033
-
Depreciation & amortisation
731
898
803
603
535
-
Stock-based compensation
19,717
27,021
21,561
13,794
4,292
-
Change in working capital
-424,364
-8,799
-228,491
284,210
9,330
-
Accounts receivable
-
-
-
-
-
0
Accounts payable
5,920
3,036
2,761
2,280
1,677
-
Other working capital
-143,819
-106,722
-112,131
511,959
-25,532
-
Other non-cash items
9
-
10
12
-35
-10
Net cash provided by operating activities
-142,836
-103,756
-111,193
513,140
-25,176
-
Cash flows from investing activities
Investments in property, plant and equipment
-983
-2,966
-938
-1,181
-356
-
Purchases of investments
-393,818
-290,541
-445,004
0
-
-
Sales/maturities of investments
432,461
366,264
0
0
-
-
Other investing activities
-120
-99
-120
-61
-21
-
Net cash used for investing activities
-1,103
72,658
-446,062
-1,242
-377
-
Cash flows from financing activities
Common stock issued
-
-
-
0
213,660
0
Common stock repurchased
-
-
-
0
-332
0
Other financing activities
-
-
1,059
716
998
65
Net cash used provided by (used for) financing activities
2,966
1,113
1,984
3,659
340,339
-
Net change in cash
-147,435
-33,587
-563,797
512,381
316,464
-
Cash at beginning of period
899,904
285,038
848,835
336,454
19,990
-
Cash at end of period
758,931
251,451
285,038
848,835
336,454
-
Free cash flow
Operating cash flow
-142,836
-103,756
-111,193
513,140
-25,176
-
Capital expenditure
-983
-2,966
-938
-1,181
-356
-
Free cash flow
-143,819
-106,722
-112,131
511,959
-25,532
-